Abstract:Acute myeloid leukemia (AML) is the most common type of acute leukemia in adults. It is estimated that 13,410 cases will be diagnosed and 8,990 will die of AML in the United States in 2007 (http://seer.cancer.gov). AML is a genetically diverse hematopoietic malignancy with variable response to treatment. Expression profiling of protein-coding genes using DNA microarray in AML has resulted in inconsistent data from different laboratories. Therefore, further validation of these observations in large cohorts and in independent studies is definitely required before clinical application becomes feasible. Recently, Golub and colleagues described a new, bead-based flow cytometric microRNA (miRNAs, miRs) expression profiling method that could successfully classify tumors. MiRNAs are endogenous ∼22 nucleotide non-coding RNAs, which can function as oncogenes and tumor suppressors. To provide new insights into the complex genetic alterations in leukemogenesis and to identify novel markers for diagnosis and treatment of AML, we performed a genome-wide analysis of miRNA expression profiles using the bead-based method on 54 AML samples with common translocations including t(15;17), t(8;21), inv(16), and 11q23 rearrangement, along with normal controls. In both unsupervised and supervised hierarchical cluster analyses, we observed that t(15;17) samples grouped together as one cluster, as do the 11q23 rearrangement samples. Interestingly, t(8;21) and inv(16), both CBF (core-binding factor) AMLs, grouped together as a unique cluster. Forty-one miRNAs exhibited significantly differential expression between different subtypes of AMLs, and/or between AMLs and normal controls. Notably, expression signature of a minimal number of two, three, and seven miRNAs could be used for class prediction of CBF, t(15;17), and 11q23 rearrangement AMLs, respectively, with an overall diagnostic accuracy of 94–96%. We further showed that overexpression of the two discriminatory miRNAs in CBF AML is associated with epigenetic regulation, rather than DNA copy number amplification. Moreover, several important target genes of these discriminatory miRNAs have also been validated. We are currently exploring the role of these discriminatory miRNAs and their critical target genes in the development of AML using in vitro and in vivo models. This work will enhance our understanding of the biological role of these miRNAs and their targets in leukemogenesis.

Retracted: Overexpression of Mir-708 and Its Targets in the Childhood Common Precursor B-cell ALL

Retracted: Overexpression Of Mir-708 And Its Targets In The Childhood Common Precursor B-Cell All (Retracted Article. See Vol.64,Pg.0,2017)

[The expression and regulatory mechanism of microRNA-708 in pediatric common B-cell acute lymphoblastic leukemia].

MiR-362-5p As a Novel Prognostic Predictor of Cytogenetically Normal Acute Myeloid Leukemia

Distinct Microrna Expression Profiles In Acute Myeloid Leukemia With Common Translocations

Downregulation of Mir-142 Promotes Leukemia Growth in Philadelphia Chromosome-Positive (ph+) Acute Lymphoblastic Leukemia (ALL): A Possible Novel Therapeutic Target?

MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.

MicroRNA Expression Profiles in Acute Myeloid Leukemia with Common Translocations.

Expression Characteristics and Prognosissignificance of Mirna-181A in Acute Myeloid Leukemia with Normal Karyotype

MicroRNA Expression Signatures Accurately Discriminate Acute Lymphoblastic Leukemia from Acute Myeloid Leukemia.

Correlation of Plasma MiR-146a,MiR-223 Levels with the Prognosis of Childhood with Acute Lymphoblastic Leukemia

Differential Microrna Expression in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia

Microrna Patterns Associated With Clinical Prognostic Parameters And Cns Relapse Prediction In Pediatric Acute Leukemia

Expression pattern of <i>miR-16-2-3p</i> and its prognostic values on pediatric acute lymphoblastic leukemia

Mir-99a May Serve As A Potential Oncogene in Pediatric Myeloid Leukemia

High Expression of Mir-25 Predicts Favorable Chemotherapy Outcome in Patients with Acute Myeloid Leukemia.

The expressions of miR-196b and its prognostic significances in pediatric acute myeloid leukemia

Association Between Expression of Plasma Mirna and the Risk of Childhood Acute Lymphocytic Leukemia

Overexpressed Mir-155 is Associated with Initial Presentation and Poor Outcome in Chinese Pediatric Acute Myeloid Leukemia.

High Level Of Mir-196b At Newly Diagnosed Pediatric Acute Myeloid Leukemia Predicts A Poor Outcome

A Set of Mirnas That Involve in the Pathways of Drug Resistance and Leukemic Stem-Cell Differentiation is Associated with the Risk of Relapse and Glucocorticoid Response in Childhood ALL